Early fusion intermediate of ACE2-using coronavirus spike acting as an antiviral target.
Xing L, Liu Z, Wang X, Liu Q, Xu W, Mao Q, Zhang X, Hao A, Xia S, Liu Z, Sun L, Zhang G, Wang Q, Chen Z, Jiang S, Sun L, Lu L.
Xing L, et al. Among authors: lu l.
Cell. 2025 Jan 24:S0092-8674(25)00041-8. doi: 10.1016/j.cell.2025.01.012. Online ahead of print.
Cell. 2025.
PMID: 39889696